Zedsen Closes $12M Series B Funding
Zedsen, a London, UK-based health tech company, raised $12m in Series B funding at a $110m valuation. The company intends to use the funds to continue to expand operations and its business reach. Led by CEO Daniel Honeywell and Dr. Caroline Hargrove, CTO, Zedsen is a health tech company with non-invasive technology that helps consumers understand their health based on data coming from their bloodstream. The companyâ€™s technology unobtrusively gathers key biological signals from the bloodstream using non-invasive sensors. Data gathered leads to hyper-personalised insights about health, fitness and diet, with support and suggestions as unique as each individual user.